Objective To determine which descriptors of cytoreductive surgical extent in advanced ovarian cancer (AOC) best predict postoperative morbidity.
Introduction
The management of advanced ovarian cancer (AOC) consists of cytoreductive surgery in conjunction with platinum-based chemotherapy. Traditionally, cytoreductive surgery has focused on pelvic, nodal and omental surgery, yet increasingly procedures to treat abdomen-wide locations of disease have been used, such as diaphragmatic, splenic, liver, and gastrointestinal resections. In spite of studies comparing European and American patients, who received more extensive surgery than UK patients, with correspondingly elevated cytoreduction rates, 1, 2 it was only in 2013 that the National Institute for Health and Care Excellence (NICE) implemented guidelines for the widespread use of such procedures in the UK, 3 an approach that was further endorsed by the Chief Medical Officer in their annual report the following year. 4 In their 2013 guidance, 3 NICE expressed caution regarding advanced cytoreductive procedures, termed 'ultra-radical' surgery, because of the elevated major morbidity rates of 12-19% seen in patients receiving such surgery, compared with 4-5% in those receiving 'standard' treatment. The NICE guidance was, therefore, defining a group with a perceived elevated risk of morbidity by the types of procedures performed, not by the number of procedures performed. This approach contrasts with previous attempts to describe the extent of surgery, such as that suggested by Alletti, 5 where the extent of surgical complexity is determined by the total number of surgical procedures performed rather than the intrinsic perceived risk of the individual procedures themselves.
Predicting which patients will have a non-standard recovery following cytoreductive surgery for advanced ovarian cancer remains elusive. Tools such as P-POS-SUM, 6 or the American College of Surgeons National Surgical Quality Improvement Program (NSQIP), 7 have limited value in accurately predicting the risk of major complications following multi-visceral resection in ovarian cancer patients. 8 A method of predicting postoperative morbidity ideally prior to, but equally at the end of, surgery would be useful for the patient, for the surgical team, and for those planning resource allocation. Such data would also enable national and international comparison.
The aim of this study was to compare the efficacy of various classifications used to describe cytoreductive surgery on their ability to predict the development of postoperative morbidity. In doing so, we sought to determine whether morbidity in cytoreductive surgery could be explained by the cumulative trauma from the number of procedures performed, rather than by the intrinsic risk profile of certain 'ultra-radical' procedures themselves.
Methods

Patients
We undertook a retrospective review of all patients diagnosed with stage-3 or -4 AOC between 16 August 2007 and 16 February 2017. All patients were managed by subspecialty trained gynaecological oncologists at the Pan-Birmingham Gynaecological Cancer Centre (PBGCC). Cases were identified from the prospectively recorded gynaecological oncology multidisciplinary team (MDT) database after approval was obtained from the hospital research and development department.
Patients were included in this study if they were referred from a local primary care provider to the PBGCC, underwent a midline laparotomy, and had a final histological diagnosis of stage-3 or -4 epithelial ovarian, tubal, or peritoneal cancer (AOC). Quaternary referrals from outside the region were excluded from this analysis. All patients were considered on an 'intention to treat' basis to allow for complete denominator data to be available.
At PBGCC, the initial assessment of women with suspected AOC consists of a clinical examination, transvaginal ultrasound scan, serum CA125 assay, and computed tomography (CT) scan of the thorax, abdomen, and pelvis. All imaging results are reviewed by specialist gynaecological cancer radiologists. Following discussion at the MDT meeting, women either undergo primary debulking surgery (PDS) or receive three or four cycles of carboplatin-based (AUC 6 with or without paclitaxel 175 mg/m 2 ) neoadjuvant chemotherapy (NACT), with an intention to consider interval debulking surgery (IDS) or palliation.
Typically, surgical procedures include pelvic clearance, omentectomy, and lymphadenectomy. More extensive surgery was introduced in 2008. In appropriately selected patients, gastrointestinal surgery or radical upper abdominal procedures are also undertaken if required. Extensive stripping of the para-aortic lymph nodes is not performed routinely, but enlarged para-aortic lymph nodes are resected. Following surgery, all histology receives central review by specialist histopathologists.
Postoperative morbidity is recorded at our institution using the Memorial Sloan Kettering Cancer Center complication grading system (Table S1) . 9, 10 For this study, only major morbidity (grades 3, 4 and 5) was recorded, with patients classified by the highest recorded complication. Morbidity was both retrospectively obtained from patients' notes and prospectively recorded following a critical incident review of major morbidity during the weekly MDT discussion.
The following data were recorded: age; body mass index (BMI); organ of origin; histological subtype; grade; stage; approach to cytoredution (primary or interval debulking surgery); cytoreductive outcome [complete (R0), optimal, <1 cm (R1), and suboptimal (R2)]; surgical complexity score (SCS); and major morbidity (grade 3+).
Data analysis
Two types of classification systems were evaluated: (1) scoring systems that assessed the types of surgery used to indicate more complex surgery; and (2) scoring systems that measured the numbers of procedures performed. Within this framework, six methods of classification were examined ( Table 1 ).
The first approach identifies high-risk surgery by the inclusion of certain procedures. Three styles of assessment were evaluated: (i) NICE classification of standard and ultra-radical surgery; (ii) Pomel classification into standard, radical, and supra-radical surgery 11 ; and (iii) a novel assessment grouping patient by the presence or absence of gastrointestinal resections.
For the purpose of this study, gastrointestinal surgery contributions to cytoreduction were considered ultra-radical if they fulfilled the criteria stated by NICE: multiple resections of the bowel (excluding localised colonic resection). 3 Patients that underwent gastrointestinal surgery that did not meet this definition were analysed in the standard surgery group. Localised colonic resection was taken to mean a recto-sigmoid resection.
The second approach examined the number of procedures performed, thereby defining higher risk surgery in terms of the cumulative surgical 'load'. Three styles of classifications were evaluated : (a) a modified SCS, as advocated by Alletti, 5 that categorised surgeries into low, intermediate, and high complexity groups (Appendix S1); (b) classification by the presence of bowel anastomoses and/or diaphragmatic surgery; and (c) classification by the presence or absence of multiple bowel resections.
The SCS was modified to include procedures outside of the SCS, with groin dissection, nephrectomy, and partial gastrectomy each giving an additional one point to the total score. With respect to diaphragmatic stripping and lymphadenectomy, points were registered only in the context of systematic regional treatment (Appendix S1).
We calculated the relative risk of major morbidity detected by the respective criteria with reference to standard surgery as defined by NICE for each of these six descriptions of surgical radicality (i, ii, and iii; a, b, and c).
No core outcome sets were relevant for this study. Furthermore, no patient involvement was required, although the results are now used in guidance for women considering cytoreductive surgery for AOC.
Statistical analysis
Categorical variables were compared with the chi-square test, and parametric and non-parametric continuous variables were compared with the analysis of variance (ANOVA) or the Kruskal-Wallis test, respectively. Survival data were calculated using the Kaplan-Meier method. All tests were two-sided, and a P value of <0.05 was regarded as being statistically significant.
Results
Between 
Analysis based on NICE classification
When classified by the NICE guidance, 453 (74.5%) patients underwent standard surgery and 155 (25.5%) patients underwent ultra-radical surgery. The overall patient demographics are demonstrated in Table 2 . The Table 2 . Overall cohort data as defined by NICE NICE Standard NICE Ultra-radical age, BMI, and grade distributions of patients were similar in both groups. IDS was performed equally frequently in the two groups (69.9 versus 64.2%, P > 0.05), but complete cytoreduction rates were significantly higher (87.7 versus 56.7%, P < 0.0001) in the ultra-radical group compared with the standard surgery group (Table 2) . Six patients (1%) died (grade-5 morbidity): as a consequence of bowel ischaemia following mesenteric thrombosis; pneumonia and acute respiratory distress syndrome (ARDS); pancreatitis leading to ARDS; pulmonary embolus; renal failure; and multi-organ failure as a result of intra-abdominal sepsis. Four of these patients received standard surgery and two received ultra-radical surgery, with corresponding mortality rates of 0.9 and 1.2%, respectively. It should, however, be noted that of the patients who underwent standard surgery, three of the four deaths occurred in sub-optimally cytoreduced patients. Major morbidity was most commonly linked to: postoperative chest drain insertion (n = 5); reoperation for bleeding/haematoma (n = 5); anastomotic leaks (n = 4); or pelvic collections (n = 4) ( Table 3) .
Analysis based on the surgical complexity score
When classified using the SCS, 400 patients underwent surgery of low complexity, 140 patients underwent surgery of intermediate complexity, and 68 patients underwent surgery of high complexity. As the SCS increased, so too did the rate of grade-3 + postoperative complications (r = 0.9). A similar trend was seen when analysing patients grouped by their SCS score with low, intermediate, and high surgical complexity groups experiencing 3.0, 10.7, and 23.5% major morbidity, respectively (Figure S1) .
A subgroup analysis was performed examining differences in major morbidity across the three SCS groups according to PDS or IDS. Major morbidity occurred in 7/ 136 (5.1%), 4/51 (7.8%), and 5/22 (22.7%) of patients undergoing low-, intermediate-, or high-complexity surgery 
Analysis of relative risks with respect to different methods of classification
Six approaches (Table 1) were evaluated on their ability to be predictive of complications relative to standard surgery as defined by NICE (Table 4) . The highest relative risks of major complications were seen in definitions assessing the number of procedures performed. Patients who underwent multiple bowel resections were nearly eight times more likely to have major postoperative morbidity than patients who had standard surgery according to the NICE classification (relative risk, RR 7.73; 95% confidence interval, 95% CI 3.92-15.26). Patients were approximately six times more likely to have a major complication relative to standard surgery as defined by NICE if they had a high SCS (RR 6.12; 95% CI 3.25-11.52), or if they received diaphragmatic surgery with gastrointestinal anastomosis (RR 5.57; 95% CI 2.65-11.72).
Definitions based upon the performance of specific procedures were less useful in identifying postoperative morbidity. Compared with patients receiving standard surgery, patients receiving ultra-radical surgery, as defined by NICE, were only four times more likely to experience major complications (RR 4.65; 95% CI 2. 26-8.79 ). This relative risk was similar to that for supra-radical surgery as defined by Pomel (RR 4.20; 95% CI 2.35-7.51); however, such definitions were marginally inferior to that of the solitary criteria of 'any gastrointestinal resection' (RR 4.69; 95% CI 2.66-8.24). Additionally, patients undergoing ultra-radical surgery, as defined by NICE, experienced 58.1% of all major complications in the cohort, whereas the definition of 'any gastrointestinal resection' identified 72.1% of all major complications (Table 4) .
To further investigate the potential for the ultra-radical definition to underestimate major morbidity, a comparison was performed amongst all patients with an SCS of 4-7 (intermediate surgical complexity), with patients subdivided into those that received standard surgery and those that received ultra-radical surgery, according to NICE. Patients undergoing surgery of intermediate complexity were used in this analysis because within this group there were 59 (42.1%) patients undergoing NICE standard surgery and 81 (57.9%) patients undergoing NICE ultra-radical surgery. Patients undergoing surgery of low complexity predominantly received NICE standard surgery, and patients undergoing surgery of high complexity predominantly received NICE ultra-radical surgery, and hence both of these groups would provide a meaningless comparison. No significant differences were seen in the rate of major morbidity between standard (6/59, 10.2%) and ultra-radical (9/81, 11.1%) procedures within the cohort who had intermediate SCS scores (P > 0.05). 
Discussion
Main findings
Our study demonstrates that the number of procedures performed significantly correlates with an increased risk of major morbidity. Additionally, we found that the number of procedures performed is a better predictor of major postoperative morbidity than the performance of certain 'high risk' procedures alone. The NICE definition of ultraradical surgery was a less useful predictor of major complications compared with the solitary criterion of 'any gastrointestinal resection'.
Strengths and limitations
The main strength of this study is the availability of total patient descriptors and the volume of cases arising from an early adopter of maximum-effort cytoreduction in the UK. As a retrospective review of practice, our results do, however, need to be interpreted with caution. Certain procedures, including liver resections and partial gastrectomies, were infrequently performed, and therefore our results may be inaccurate in patients undergoing these procedures. Furthermore, given the high rate of IDS observed in this study, our findings may be less generalisable to centres performing a greater proportion of PDS. We appreciate the wide confidence intervals and recommend a suitably powered, prospective study to confirm our findings.
Interpretation
As the extent of surgery increases, so too does the risk of major morbidity. It is hardly surprising that patients treated with 'ultra-radical' surgery experience higher rates of major complications than patients managed with standard surgery. [16] [17] [18] Although surgical complexity has long been associated with postoperative morbidity, [19] [20] [21] our study is the first to demonstrate that standard and 'ultra-radical' surgery of similar surgical complexities have similar major complication rates, suggesting that the actual number of procedures performed is a more important driver of postoperative morbidity than the procedure types themselves.
Of the five studies originally describing morbidity following the introduction of advanced surgical procedures, all can be considered studies of an ethos change towards multi-visceral resection, and thus it is unsurprising that all demonstrated a mean number of advanced procedures per patient of between 1.6 and 2.2. 2, [16] [17] [18] 22 Similar results were seen in single-centre studies examining isolated organ resection in cytoreductive surgery. Magtigbays' study of 112 patients undergoing splenectomy witnessed 61 additional urological/ colorectal procedures. 23 Tsoloakidids' study of 89 patients undergoing diaphragmatic resection saw 32 additional advanced procedures used. 24 Isolated pelvic disease is uncommon in AOC, 25 and hence multiple advanced procedures may be required to achieve cytoreductive targets.
Our findings indicate that the morbidity risk is higher after high-complexity surgery, diaphragmatic surgery with a colorectal anastomosis, and multiple bowel resections. This supports the theory that the overall surgical 'load' is a significant driver of postoperative morbidity, and is a better predictor than certain specific procedures.
'Ultra-radical' procedures have been used in isolation in other conditions with acceptable safety profiles, [26] [27] [28] and the previous reviews of advanced surgical procedures at the PBGCC only observed significantly increased morbidity in patients who underwent multi-visceral resections. 12, 29 In Alleti's paper, although surgical complexity was associated with major morbidity, subgroup analysis did not demonstrate a difference between various age and morbidity groups at similar surgical complexity levels. 20 Similar findings were seen when the age-adjusted Charleston comorbidity index was used in primary and interval cytoreductive surgeries. 10, 14 Such surprising results may be caused by insufficient power, as all studies showed a non-significant increase in postoperative morbidity with increasing age and morbidity. Therefore, a meta-analysis would be strongly recommended. It is likely that other factors manipulate the baseline risk, such as: serum albumin; performance status; age; and pre-operative morbidities. In our study, despite the high rate of patients undergoing surgery, the risk from intervention may be underestimated in the elderly or in patients with co-morbidity. It is essential that large core outcome data sets are developed with pooling of data to better describe individual patients' risks of postoperative morbidity. Such data would give an additional way of benchmarking the performance of centres, in addition to general cohort descriptors and survival data. 13 Attempts to describe the postoperative course for individual patients have proven difficult in the gynaecological oncological setting. Pre-operative predictors of morbidity, such as P-POSSUM, 6 or the American College of Surgeons National Surgical Quality Improvement Program (NSQIP), 7 have limited value in accurately predicting the risk of major complications following multi-visceral resection in ovarian cancer patients. 8 Although international guidance incorporates complications rates into the therapeutic pathways, predicting postoperative morbidity in cytoreductive surgery for individual patients remains elusive. 30 The SCS is a marker of surgical 'load', both as a measure of numbers of procedures as well as a weighting of each of the constituent parts. Although we have modified the SCS to include groin lymphadenectomy, nephrectomy, and gastrectomy, our weighting was arbitrarily set at 1. There are also procedures worthy of inclusion, such as resection around the porta hepatis, the lesser sac, and coeliac axis, and further studies to define what weight the SCS should give to these procedures should be encouraged. Despite this limitation, our study shows postoperative morbidity positively correlating with Aletti's SCS. Additionally, it demonstrates that the relative risk of major morbidity is higher with definitions that assess numbers of procedures rather than those that assess types of procedures. We suggest that assessing surgery load is more useful than looking at what surgery is to be performed. It could be argued that the numbers of procedures needed cannot be predicted preoperatively, but studies pertaining to the preoperative prediction of required surgery have often focused on resectibility rather than surgical complexity. 31 If it is considered appropriate to proceed with surgery, we suggest that a crude assessment of the surgical complexity required can be achieved using clinical examination, cross-sectional imaging, and, in selective cases, diagnostic laparoscopy. This assessment would allow for more informed patient choice regarding whether to undergo surgery.
In its next review of the guidance regarding ultra-radical surgery, we urge NICE to clarify the role of gastrointestinal surgery in both standard and ultra-radical settings. In its present state, NICE defines 'standard' surgery as 'radical' with constituent parts of 'bilateral salpingo-oophorectomy, total abdominal hysterectomy, omentectomy and lymphadenectomy', 3 with no mention of bowel surgery. Ultraradical surgery, however, requires 'multiple resections of the bowel (excluding localised colonic resection)'. 3 There therefore remains a grey area between standard and ultraradical surgery encompassing single gastrointestinal resections, especially of the small bowel and the extent of resection that renders a colonic resection 'localised'.
In our study, the NICE definition of ultra-radicality failed to predict morbidity when compared with 'any gastro-intestinal resection'. We therefore need to use a more accurate classification of surgical radicality to better inform patients, surgeons, and resource allocators in the management of AOC.
Conclusion
Defining cytoreductive surgery in AOC in a meaningful way remains elusive. Traditional terms such as standard, radical, supra-radical, or ultra-radical reflect on the progression of gynaecological oncology surgery from limited pelvic surgery to the abdomen-wide surgery required to cover the distribution of the disease. Such terms are emotive, are often poorly defined, and do little to quantify the risks for patients. The numbers of procedures performed appears to be a more significant predictor of morbidity. We suggest using the approach advocated by Aletti to define a higher risk operation, and suggest that it should be the basis of any future development by NICE regarding the acceptable extent of surgery.
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